Know Cancer

or
forgot password
  • cancer clinical trials in hackensack, NJ

  • A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    T-cell Non-Hodgkin's Lymphoma
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Unspecified Childhood Solid Tumor, Protocol Specific
    Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia, Multiple Myeloma, Hematological Cancers, Psychological Distress
    Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
    Hackensack University Medical Center Dept ofHackensackUniversityMC
    Hackensack, New Jersey 07601
    Lymphoma, Mantle- Cell
    Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 22443
    Hackensack, New Jersey 07601
    Advanced or Metastatic Non-Small Cell Lung Cancer
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Sarcoma
    Assess the Oral Bioavailability of New ABT-263 Formulations
    Site Reference ID/Investigator# 20041
    Hackensack, New Jersey 07601
    Chronic Lymphocytic Leukemia, Lymphomas, Leukemias
    Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
    John Theurer Cancer Center, Hackensack University Medical Center,
    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia, AML
    Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
    Northern New Jersey Cancer Associates
    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    The Cancer Center, Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia
    A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Mantle Cell Lymphoma
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Transfusional Hemosiderosis
    Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Metastatic Androgen Independent Prostate Cancer
    Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
    John Theurer Cancer Center
    Hackensack, New Jersey 07601
    Advanced Cancer, Various, NOS
    Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    EBV Lymphomas, Lympho-proliferative Diseases
    An SGN-35 Trial for Patients Who Have Previously Participated in an SGN-35 Study
    The John Theurer Cancer Center, Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Lymphoid Malignancies, Lymphoproliferative Disorders
    Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
    Hackensack Univ. Medical Center
    Hackensack, New Jersey 07601
    Graft-versus-Host Disease, Immune System Disorders
    A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Lymphoid Malignancies
    A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Metastatic Pancreatic Cancer
    A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

    Hackensack, New Jersey 07601
    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
    A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma
    Site Reference ID/Investigator# 61522
    Hackensack, New Jersey 07601
    B-cell Small Lymphocytic Lymphoma Recurrent
    First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer
    In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Graft Versus Host Disease
    Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
    John Theurer Cancer Center Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
    Expanded Access Program of Ponatinib
    John Theurer Cancer Center at Hackensack University Medical Center, Site 128
    Hackensack, New Jersey 07601
    Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    Hackensack University Medical Center SC-2
    Hackensack, New Jersey 07601
    Metastatic or Unresectable Cutaneous Melanoma
    A Long-term Extension Study of PCI-32765 (Ibrutinib)

    Hackensack, New Jersey 07601
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma
    A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
    John Theurer Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Relapsed Waldenström's Macroglobulinemia (WM)., Prior Bortezomib Therapy Acceptable.